About Igenerix Pharma Private Limited
Data last updated:
Igenerix Pharma Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 05 February 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U73200UP2008PTC170816. Its GSTIN is 09AABCI8226N1Z4 (Uttar Pradesh). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1 Lakh. It is led by directors Arvinder Singh Sodhi and Jyoti Rawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No – 702 Tower – 1 Assotech Business Cresterra Plot No. 22 Sector 135 Expressway, Noida, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2021, the company reported a revenue of ₹4.42 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹16.78 Lakh (net margin 3.8%) and EBITDA of ₹10.19 Lakh (EBITDA margin 2.3%). Revenue has grown at a compounded annual rate (CAGR) of 71% over three years and 29% over five years.
The company is associated with 1 brand: Igenerix Pharma.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website igenerixpharma.com.
CIN History of Igenerix Pharma Private Limited
Igenerix Pharma has one previous CIN (Corporate Identification Number): U73200KA2008PTC045183. The current CIN is U73200UP2008PTC170816, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73200UP2008PTC170816 | Current |
| U73200KA2008PTC045183 | Previous |
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressUnit No – 702 Tower – 1 Assotech Business Cresterra Plot No. 22 Sector 135 Expressway, Noida, Uttar Pradesh, India – 201301
- IndustryLife Sciences, Biotechnology
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Igenerix Pharma Private Limited
Igenerix Pharma operates one associated brand: Igenerix Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Life sciences support services including representation, consulting, and procurement for global market entry. | igenerixpharma.com |
Financials of Igenerix Pharma Private Limited FY 2025 filings available
Igenerix Pharma Private Limited reported revenue of ₹4.42 Cr (down 11% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR) of Igenerix Pharma Private Limited
Revenue fell 11% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 29%. EBITDA fell 74% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Igenerix Pharma Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹4.42 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹10.19 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹16.78 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Igenerix Pharma Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Igenerix Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Igenerix Pharma Private Limited
Igenerix Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arvinder Singh Sodhi Also directs: Hampton Pharma Private Limited | Director | 05 Feb 2008 | 18 Years 8 Months | Current |
| Jyoti Rawal Also directs: Hampton Pharma Private Limited | Director | 03 Nov 2011 | 14 Years 11 Months | Current |
Auditor Details of Igenerix Pharma Private Limited
Igenerix Pharma Private Limited is audited by DINESH BHATKAL & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DINESH BHATKAL & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Igenerix Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Igenerix Pharma Private Limited
Igenerix Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Igenerix Pharma Private Limited
Employment history and EPFO contributions of people linked to Igenerix Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Igenerix Pharma Private Limited
Igenerix Pharma Private Limited has 5 board changes on record since 2008: 2 appointments and 3 cessations. The latest: Kamal Singh Sodhi ceased to be Director on 04 Nov 2011.
Credit Ratings, Litigation & Regulatory Alerts for Igenerix Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Igenerix Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Igenerix Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Igenerix Pharma Private Limited
Igenerix Pharma has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCI8226N1Z4 | Uttar Pradesh | Active | 15 Sep 2017 |
| 29AABCI8226N2Z1 | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Igenerix Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Igenerix Pharma Private Limited
Igenerix Pharma is an active private limited company based in Noida, Uttar Pradesh, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 05 February 2008 (18+ years old) and is registered under CIN U73200UP2008PTC170816.
Igenerix Pharma reported revenue of ₹4.42 Cr for FY 2021 (down 11% YoY).
Igenerix Pharma has 2 current directors:
- Arvinder Singh Sodhi - Director
- Jyoti Rawal - Director
Igenerix Pharma reported a net profit of ₹16.78 Lakh (net margin 3.8%) and EBITDA of ₹10.19 Lakh (EBITDA margin 2.3%) for FY 2021, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Igenerix Pharma is 71% over three years and 29% over five years. In the latest year (FY 2021) revenue fell 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Igenerix Pharma is 09AABCI8226N1Z4, registered in Uttar Pradesh. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 29AABCI8226N2Z1 (Karnataka).
The CIN (Corporate Identification Number) of Igenerix Pharma is U73200UP2008PTC170816. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Igenerix Pharma was incorporated on 05 February 2008, making it 18+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Kamal Singh Sodhi ceased to be Director on 04 Nov 2011. Jyoti Rawal was appointed as Director on 03 Nov 2011. Neeraja Shetty ceased to be Director on 18 Oct 2011. Igenerix Pharma has 5 board changes on record in total.
Igenerix Pharma can be reached through the website igenerixpharma.com. Its registered office is in Noida, Uttar Pradesh, India.